Chemists laid off at GlaxoSmithKline


GlaxoSmithKline's June announcement that it was cutting 350 jobs worldwide is coming to fruition. The company just laid off 22 scientists at its Medicinal Chemistry and Oncology Department in Research Triangle Park, North Carolina. 

Already this summer, the company laid off nearly 200 workers, with half in its research department in June and about 90 more from a manufacturing plant in Zebulon.  Company spokespeople say its just part of GSK's overall R&D "restructuring" plan to increase research and development and make manufacturing more efficient.

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.